Showing results (771-780 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 29, 2005
Considerations for a WHO European strategy on health-care-associated infection, surveillance, and controlDidier Pittet, Benedetta Allegranzi, Hugo Sax, et al.
The Lancet. Infectious Diseases|March 29, 2005
Natural history and pathophysiology of Q feverD Raoult, Tj Marrie, Jl Mege
The Lancet. Infectious Diseases|March 29, 2005
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relationsDomenico Sansonno, Franco Dammacco
The Lancet. Infectious Diseases|May 4, 2004
Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?Silvia F Costa, Marisa H Miceli, Elias J Anaissie
The Lancet. Infectious Diseases|May 4, 2004
Infections related to the ingestion of seafood. Part II: parasitic infections and food safetyAdeel A Butt, Kenneth E Aldridge, Charles V Sanders
The Lancet. Infectious Diseases|February 1, 2005
Infection in breast implantsBrigitte Pittet, Denys Montandon, Didier Pittet
The Lancet. Infectious Diseases|December 23, 2021
Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend studyYang Zheng, Qi Yu, Yushi Lin, et al.
The Lancet. Infectious Diseases|December 2, 2021
Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trialEveline Hürlimann, Ladina Keller, Chandni Patel, et al.
The Lancet. Infectious Diseases|September 5, 2022
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational studyMegan Bardsley, Roger A Morbey, Helen E Hughes, et al.
The Lancet. Infectious Diseases|September 10, 2022
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialMehreen S Datoo, Hamtandi Magloire Natama, Athanase Somé, et al.
Pageof 270